Merck Halts Gardasil Lobbying Efforts Following Discussions With ACIP, AAP
Executive Summary
Merck decided to halt lobbying efforts for state legislation requiring vaccination with its human papilloma virus vaccine Gardasil for school entry following discussions with third party stakeholders, including CDC's Advisory Committee on Immunization Practices and the American Academy of Pediatrics, the company said
You may also be interested in...
Vaccine Irony: COVID Complicates Review, Uptake Of New RSV Vaccines
COVID vaccines saved the world and then became a liability. US FDA vaccine advisors cited COVID experience as they urge agency to slow down on approval of new RSV vaccines, due to worries of declining public vaccine confidence and coadministration complications.
HIV Vaccine Trials: FDA Mulls Ethics Of Enrolling Teens; Is Phase II Too Soon?
The first approved HIV vaccine should be initially indicated for both adolescent and adult populations, but how and when to enroll adolescents in clinical trials is less straightforward, FDA's Pediatric Ethics Subcommittee determined at a June 9 meeting
HIV Vaccine Trials: FDA Mulls Ethics Of Enrolling Teens; Is Phase II Too Soon?
The first approved HIV vaccine should be initially indicated for both adolescent and adult populations, but how and when to enroll adolescents in clinical trials is less straightforward, FDA's Pediatric Ethics Subcommittee determined at a June 9 meeting